Transcriptional Activation of Human MMP-13 Gene Expression by c-Maf in Osteoarthritic Chondrocyte

REFERENCES

• Martel-Pelletier, J. (2004). Pathophysiology of osteoarthritis. Osteoarthr. Cart., 12 Suppl A, S31–S33.
   PubMedGoogle Scholar
• Kamekura, S., Hoshi K., Shimoaka, T., (2005). Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthr. Carti., 13, 632–641.
   PubMed Web of Science ®Google Scholar
• Mengshol, J.A., Vincenti, M.P., and Brinckerhoff, C.E. (2001). IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res., 29, 4361–4372.
   PubMed Web of Science ®Google Scholar
• Liacini, A., Sylvester, J., Li, W.Q., (2003). Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp. Cell. Res., 288, 208–217.
   PubMed Web of Science ®Google Scholar
• Benderdour, M., Tardif, G., Pelletier, J.P., (2002). Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta. J. Rheumatol., 29, 1262–1272.
   PubMed Web of Science ®Google Scholar
• Brinckerhoff, C.E. and Matrisian, L.M. (2002). Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell. Biol., 3, 207–214.
   PubMed Web of Science ®Google Scholar
• Vincenti, M.P., White, L.A., Schroen, D.J. (1996). Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit. Rev. Eukaryot. Gene Expr., 6, 391–411.
   PubMed Web of Science ®Google Scholar
• Kataoka, K., Nishizawa, M., and Kawai S. (1993). Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family. J. Virol., 67, 2133–2141.
   PubMedGoogle Scholar
• Nishizawa, M., Kataoka, K., Goto, N., (1989). v-maf, a viral oncogene that encodes a “leucine zipper” motif. Proc. Natl. Acad. Sci. USA, 86, 7711–7715.
   PubMed Web of Science ®Google Scholar
• Kataoka, K., Noda, M., and Nishizawa, M. (1994). Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol. Cell. Biol., 14, 700–712.
   PubMed Web of Science ®Google Scholar
• Kerppola, T.K. and Curran, T. (1994). A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins. Oncogene, 9, 3149–3158.
   PubMed Web of Science ®Google Scholar
• MacLean, H.E., Kim, J.I., Glimcher, M.J., (2003). Absence of transcription factor c-maf causes abnormal terminal differentiation of hypertrophic chondrocytes during endochondral bone development. Dev. Biol., 262, 51–63.
   PubMed Web of Science ®Google Scholar
• Ahmed, S., Rahman, A., Hasnain, A., (2002). Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic. Biol. Med., 33, 1097–1105.
   PubMed Web of Science ®Google Scholar
• Lin, Z., Pavlos, N.J., Cake, M.A., (2008). Evidence that human cartilage and chondrocytes do not express calcitonin receptor. Osteoarthr. Cart., 16, 450–457.
   PubMed Web of Science ®Google Scholar
• Benderdour, M., Tardif, G., Pelletier, J.P., (2002). A novel negative regulatory element in the human collagenase-3 proximal promoter region. Biochem. Biophys. Res. Commun., 291, 1151–1159.
   PubMed Web of Science ®Google Scholar
• Chow, G., Nietfeld, J.J., Knudson, C.B., (1998). Antisense inhibition of chondrocyte CD44 expression leading to cartilage chondrolysis. Arthr. Rheum., 41, 1411–1419.
   PubMed Web of Science ®Google Scholar
• Hurt, E.M., Wiestner, A., Rosenwald, A., (2004). Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell, 5, 191–199.
   PubMed Web of Science ®Google Scholar
• Morito, N., Yoh, K., Fujioka, Y., (2006). Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human. Cancer Res., 66, 812–819.
   PubMed Web of Science ®Google Scholar
• Li, T., Xiao, J., Wu, Z., (2009). Over-expression of c-maf by chondrocytes in osteoarthritis. J. Int. Med. Res., 37, 129–135.
   PubMed Web of Science ®Google Scholar
• Selvamurugan, N., Fung, Z., and Partridge, N.C. (2002). Transcriptional activation of collagenase-3 by transforming growth factor-beta1 is via MAPK and Smad pathways in human breast cancer cells. FEBS Lett., 532, 31–35.
   PubMed Web of Science ®Google Scholar
• Guevremont, M., Martel-Pelletier, J., Massicotte, F., (2003). Human adult chondrocytes express hepatocyte growth factor (HGF) isoforms but not HgF: potential implication of osteoblasts on the presence of HGF in cartilage. J. Bone Miner. Res., 18, 1073–1081.
   PubMed Web of Science ®Google Scholar
• Yokota, H., Goldring, M.B., and Sun, H.B. (2003). CITED2-mediated regulation of MMP-1 and MMP-13 in human chondrocytes under flow shear. J. Biol. Chem., 278, 47275–47280.
   PubMed Web of Science ®Google Scholar
• Forsyth, C.B., Pulai, J., and Loeser, R.F. (2002). Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthr. Rheum., 46, 2368–2376.
   PubMed Web of Science ®Google Scholar
• Tardif, G., Reboul, P., Dupuis, M., (2001). Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites. J. Rheumatol., 28, 1631–1639.
   PubMed Web of Science ®Google Scholar
• Hess, J., Porte, D., Munz, C., (2001). AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J. Biol. Chem., 276, 20029–20038.
   PubMed Web of Science ®Google Scholar
• Lu, T., Achari, Y., Sciore, P., (2006). Estrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site. Biochim. Biophys. Acta, 1762, 719–731.
   PubMed Web of Science ®Google Scholar
• Appleton, C.T., McErlain, D.D., Henry, J.L., (2007). Molecular and histological analysis of a new rat model of experimental knee osteoarthritis. Ann. NY Acad. Sci., 1117, 165–174.
   PubMed Web of Science ®Google Scholar
• D’Angelo, M., Yan, Z., Nooreyazdan, M., (2000). MMP-13 is induced during chondrocyte hypertrophy. J. Cell. Biochem., 77, 678–693.
   PubMed Web of Science ®Google Scholar
• Pullig, O., Weseloh, G., Ronneberger, D., (2000). Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcif. Tissue. Int., 67, 230–240.
   PubMed Web of Science ®Google Scholar
• Hellio Le Graverand, M.P., Eggerer, J., Sciore, P., (2000). Matrix metalloproteinase-13 expression in rabbit knee joint connective tissues: influence of maturation and response to injury. Matrix Biol., 19, 431–441.
   PubMed Web of Science ®Google Scholar
• Vincenti, M.P. and Brinckerhoff, C.E. (2002). Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthr. Res., 4, 157–164.
   PubMedGoogle Scholar